BELVAPE: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
BELVAPE
Largest movements
No asset line moved by more than 1% of the balance sheet total.
No liability line moved by more than 1% of the balance sheet total.
- Financial income +€48,625
up €48,625 (+57.5%), from €84,584 to €133,209
- Other operating charges +€5,431
up €5,431 (+5.0%), from €108,000 to €113,431
- Gross operating margin -€1,276
new in 2025: -€1,276
- Purchases and services +€1,276
new in 2025: €1,276
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €7,980,183 | €7,999,895 | +€19,712 | +0.2% |
| Current assets | 29/58 | €7,980,183 | €7,999,895 | +€19,712 | +0.2% |
| Amounts receivable within one year | 40/41 | €21,854 | €35,146 | +€13,293 | +60.8% |
| Other amounts receivable | 41 | €21,854 | €35,146 | +€13,293 | +60.8% |
| Current investments | 50/53 | €7,958,327 | €7,942,893 | -€15,434 | -0.2% |
| Cash at bank and in hand | 54/58 | €2 | €21,856 | +€21,854 | +1,098,166% |
| Total equity and liabilities | 10/49 | €7,980,183 | €7,999,895 | +€19,712 | +0.2% |
| Equity | 10/15 | €7,980,183 | €7,998,685 | +€18,502 | +0.2% |
| Contributions | 10/11 | €25,300 | €25,300 | = | 0.0% |
| Capital | 10 | €25,300 | €25,300 | = | 0.0% |
| Issued capital | 100 | €25,300 | €25,300 | = | 0.0% |
| Reserves | 13 | €7,954,883 | €7,973,385 | +€18,502 | +0.2% |
| Non-distributable reserves | 130/1 | - | €2,530 | +€2,530 | |
| Legal reserve | 130 | - | €2,530 | +€2,530 | |
| Tax-exempt reserves | 132 | €16,054 | €16,054 | = | 0.0% |
| Distributable reserves | 133 | €7,938,829 | €7,954,801 | +€15,972 | +0.2% |
| Amounts payable | 17/49 | - | €1,210 | +€1,210 | |
| Amounts payable within one year | 42/48 | - | €1,210 | +€1,210 | |
| Trade debts | 44 | - | €1,210 | +€1,210 | |
| Suppliers | 440/4 | - | €1,210 | +€1,210 | |
| Goods, raw materials, services and sundry goods | 60/61 | - | €1,276 | +€1,276 | |
| Other operating charges | 640/8 | €108,000 | €113,431 | +€5,431 | +5.0% |
| Gross operating margin | 9900 | - | -€1,276 | -€1,276 | |
| Operating profit (loss) | 9901 | -€108,000 | -€114,707 | -€6,707 | -6.2% |
| Financial income | 75/76B | €84,584 | €133,209 | +€48,625 | +57.5% |
| Recurring financial income | 75 | €84,584 | €133,209 | +€48,625 | +57.5% |
| Profit (loss) for the period before taxes | 9903 | -€23,415 | €18,502 | +€41,918 | |
| Profit (loss) for the period | 9904 | -€23,415 | €18,502 | +€41,918 | |
| Profit (loss) for the period to be appropriated | 9905 | -€23,415 | €18,502 | +€41,918 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 13 October 2026 via checked.be.